We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
+10.03%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$39.6B
AUM Growth
+$2.78B
(+7.6%)
Cap. Flow
-$224M
Cap. Flow
% of AUM
-0.57%
Top 10 Holdings %
Top 10 Hldgs %
25.25%
Holding
1,779
New
108
Increased
532
Reduced
495
Closed
39
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$141M |
| 2 |
Meta Platforms (Facebook)
META
|
+$55.8M |
| 3 |
Analog Devices
ADI
|
+$48.7M |
| 4 |
Amazon
AMZN
|
+$47.8M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$45.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$88.7M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$70.5M |
| 3 |
Johnson & Johnson
JNJ
|
+$64.2M |
| 4 |
Apple
AAPL
|
+$62M |
| 5 |
RB Global
RBA
|
+$55.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.88% |
| 2 | Healthcare | 15.94% |
| 3 | Financials | 12.41% |
| 4 | Consumer Discretionary | 10.84% |
| 5 | Industrials | 8.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
Wabash National
WNC
$541M
| $612K | ﹤0.01% |
51,171
| – | – |
|
1477
Tanger
SKT
$4.84B
| $611K | ﹤0.01% |
101,350
| – | – |
|
1478
Oxford Industries
OXM
$613M
| $604K | ﹤0.01% |
14,965
| – | – |
|
1479
Syndax Pharmaceuticals
SNDX
$1.74B
| $604K | ﹤0.01% |
40,977
+23,023
| +128% | +$351K |
|
1480
Enova International
ENVA
$6.2B
| $603K | ﹤0.01% |
36,800
| – | – |
|
1481
Corcept Therapeutics
CORT
$10.1B
| $600K | ﹤0.01% |
34,500
| – | – |
|
1482
ATN International
ATNI
$370M
| $597K | ﹤0.01% |
11,898
| – | – |
|
|
RPTX
1483
DELISTED
Repare Therapeutics
RPTX
| $597K | ﹤0.01% |
19,400
+17,400
| +870% | +$461K |
|
|
AKRO
1484
DELISTED
Akero Therapeutics
AKRO
| $595K | ﹤0.01% |
19,321
-7,881
| -29% | -$275K |
|
1485
BCE
BCE
$20.3B
| $592K | ﹤0.01% |
13,916
-9,456
| -40% | -$400K |
|
1486
OneSpan
OSPN
$572M
| $591K | ﹤0.01% |
28,219
| – | – |
|
1487
Ubiquiti
UI
$32.4B
| $590K | ﹤0.01% |
3,540
+2,490
| +237% | +$439K |
|
1488
Matthews International
MATW
$900M
| $588K | ﹤0.01% |
26,301
| – | – |
|
1489
AAR Corp
AIR
$5.62B
| $587K | ﹤0.01% |
31,223
| – | – |
|
1490
Deutsche Bank
DB
$67.6B
| $586K | ﹤0.01% |
72,650
-11,350
| -14% | -$106K |
|
1491
OFG Bancorp
OFG
$2.24B
| $586K | ﹤0.01% |
46,999
| – | – |
|
|
DRNA
1492
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $586K | ﹤0.01% |
+32,573
| New | +$674K |
|
1493
PBF Energy
PBF
$7.22B
| $582K | ﹤0.01% |
102,317
| – | – |
|
1494
3D Systems Corp
DDD
$412M
| $576K | ﹤0.01% |
117,343
| – | – |
|
1495
Adeia
ADEA
$2.77B
| $574K | ﹤0.01% |
188,887
| – | – |
|
1496
Eagle Bancorp
EGBN
$866M
| $573K | ﹤0.01% |
21,400
| – | – |
|
|
GTM
1497
ZoomInfo Technologies
GTM
$967M
| $573K | ﹤0.01% |
13,319
-36,681
| -73% | -$1.44M |
|
1498
Match Group
MTCH
$9.16B
| $570K | ﹤0.01% |
+5,155
| New | +$546K |
|
1499
Anika Therapeutics
ANIK
$202M
| $566K | ﹤0.01% |
16,000
| – | – |
|
|
MDP
1500
DELISTED
Meredith Corporation
MDP
| $564K | ﹤0.01% |
42,970
| – | – |
|
Similar funds
SCP
Ensign Peak Advisors's Q3 2020 Portfolio in Review
As of Q3 2020, Ensign Peak Advisors held 1,779 positions worth $39.6B, up 7.6% from $36.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Ensign Peak Advisors's Q3 2020 filing shows 108 new, 532 increased, 495 reduced and 39 closed positions. Its largest new stake was Whiting Petroleum Corporation: 475,126 shares worth $8.21M. The largest sale was Intel, an estimated $88.7M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Ensign Peak Advisors's largest Q3 2020 buy was Whiting Petroleum Corporation: 475,126 shares worth $8.21M.
- Ensign Peak Advisors added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $141M increase.
- Ensign Peak Advisors's biggest Q3 2020 reduction was Intel, cutting an estimated $88.7M.
- Ensign Peak Advisors fully exited Novartis in Q3 2020, selling an estimated $9.96M.
- Ensign Peak Advisors's ten largest holdings make up 25% of its $39.6B portfolio in Q3 2020.
- Ensign Peak Advisors opened 108 new positions and closed 39 in Q3 2020.
- Ensign Peak Advisors's portfolio value rose 7.6% quarter-over-quarter to $39.6B.
Based on Ensign Peak Advisors's 13F filing for Q3 2020, filed 12 Nov 2020.